Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-0904|6|2|258-261

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.6, Iss.2, 2018-02, pp. : 258-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

By Fritsch P.O.   Sidoroff A.  

American Journal of Clinical Dermatology, Vol. 1, Iss. 6, 2000-11 ,pp. : 349-360

Adis International

Access to resources Recommend Favorite

Intravenous Immunoglobulin Use in Patients with Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome

By Mittmann Nicole  

American Journal of Clinical Dermatology, Vol. 7, Iss. 6, 2006-01 ,pp. : 359-368

Adis International

Access to resources Recommend Favorite

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap due to Oral Temozolomide and Cranial Radiotherapy

By Sarma Nilendu  

American Journal of Clinical Dermatology, Vol. 10, Iss. 4, 2009-06 ,pp. : 264-267

Adis International

Access to resources Recommend Favorite

Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort: An Observational, Retrospective Case Series Study

By Mittmann Nicole  

American Journal of Clinical Dermatology, Vol. 13, Iss. 1, 2012-02 ,pp. : 49-54

Adis International

Access to resources Recommend Favorite

Toxic Epidermal Necrolysis in Oncologic Patients

By Gravante Gianpiero  

American Journal of Clinical Dermatology, Vol. 7, Iss. 6, 2006-01 ,pp. : 397-398

Adis International

Access to resources Recommend Favorite